Search research articles
Contact Us
Filters
Showing results (241-250 of 287) with videos related to
Page
of 29
Sort By:
Virchows Archiv : an International Journal of Pathology
|
October 16, 2014
Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist
Rodolfo Montironi, Elizabeth H Hammond, Daniel W Lin, et al.
Clinical Genitourinary Cancer
|
September 12, 2024
Small Cell Bladder Cancer: Treatment Patterns for Local Disease and Associated Outcomes. A Retrospective Cohort Study
Dimitra Rafailia Bakaloudi, Elizabeth L Koehne, Leonidas N Diamantopoulos, et al.
Pathology
|
December 5, 2014
Active surveillance for prostate cancer: the role of the pathologist
Brett Delahunt, Elizabeth Hammond, Lars Egevad, et al.
Cancer
|
April 20, 2017
Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT study
John L Gore, Marguerite du Plessis, María Santiago-Jiménez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2017
Neoadjuvant Enzalutamide Prior to Prostatectomy
Bruce Montgomery, Maria S Tretiakova, Anthony M Joshua, et al.
The Journal of Clinical Investigation
|
July 31, 2019
Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer
Mark P Labrecque, Ilsa M Coleman, Lisha G Brown, et al.
Urology
|
August 2, 2008
A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer
Edouard J Trabulsi, Richard K Valicenti, Alexandra L Hanlon, et al.
Clinical Genitourinary Cancer
|
November 8, 2020
Response to Neoadjuvant Chemotherapy and Survival in Micropapillary Urothelial Carcinoma: Data From a Tertiary Referral Center and the Surveillance, Epidemiology, and End Results (SEER) Program
Leonidas N Diamantopoulos, Sarah K Holt, Ali R Khaki, et al.
The Journal of Urology
|
September 10, 2021
Reply by Authors
Lauren Folgosa Cooley, Adaeze A Emeka, Travis J Meyers, et al.
The Journal of Urology
|
September 10, 2021
Factors Associated with Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional Cohort
Lauren Folgosa Cooley, Adaeze A Emeka, Travis J Meyers, et al.
Page
of 29
Search research articles
Search
Showing results (241-250 of 287) with videos related to
Sort By:
Page
of 29
Virchows Archiv : an International Journal of Pathology
|
October 16, 2014
Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist
Rodolfo Montironi, Elizabeth H Hammond, Daniel W Lin, et al.
Clinical Genitourinary Cancer
|
September 12, 2024
Small Cell Bladder Cancer: Treatment Patterns for Local Disease and Associated Outcomes. A Retrospective Cohort Study
Dimitra Rafailia Bakaloudi, Elizabeth L Koehne, Leonidas N Diamantopoulos, et al.
Pathology
|
December 5, 2014
Active surveillance for prostate cancer: the role of the pathologist
Brett Delahunt, Elizabeth Hammond, Lars Egevad, et al.
Cancer
|
April 20, 2017
Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT study
John L Gore, Marguerite du Plessis, María Santiago-Jiménez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2017
Neoadjuvant Enzalutamide Prior to Prostatectomy
Bruce Montgomery, Maria S Tretiakova, Anthony M Joshua, et al.
The Journal of Clinical Investigation
|
July 31, 2019
Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer
Mark P Labrecque, Ilsa M Coleman, Lisha G Brown, et al.
Urology
|
August 2, 2008
A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer
Edouard J Trabulsi, Richard K Valicenti, Alexandra L Hanlon, et al.
Clinical Genitourinary Cancer
|
November 8, 2020
Response to Neoadjuvant Chemotherapy and Survival in Micropapillary Urothelial Carcinoma: Data From a Tertiary Referral Center and the Surveillance, Epidemiology, and End Results (SEER) Program
Leonidas N Diamantopoulos, Sarah K Holt, Ali R Khaki, et al.
The Journal of Urology
|
September 10, 2021
Reply by Authors
Lauren Folgosa Cooley, Adaeze A Emeka, Travis J Meyers, et al.
The Journal of Urology
|
September 10, 2021
Factors Associated with Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional Cohort
Lauren Folgosa Cooley, Adaeze A Emeka, Travis J Meyers, et al.
Page
of 29